Gene set identifies glioblastomas most vulnerable to promising therapeutic

by Becky Ham,Translational Genomics Research InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers from TGen, part of City of Hope, and from the University of Califo

Updated on: July 17,2024 0

Gene set identifies glioblastomas most vulnerable to promising therapeutic

by Becky Ham,Translational Genomics Research InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers from TGen, part of City of Hope, and from the University of Califo

Updated on:July 17,2024 0

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which

Updated on: July 17,2024 0

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which

Updated on:July 17,2024 0

The Sweet Dilemma: Fructose's Impact on Cancer and Immunity

Updated on: July 13,2024 0

The Sweet Dilemma: Fructose's Impact on Cancer and Immunity

Updated on:July 13,2024 0

Research supports TCM liver-breast cancer theory: Fatty liver linked to deteriorating breast cancer

byThe University of Hong KongA) Trial schematic for establishing an HFD-fed NAFLD-breast cancer mice model. B, C) Mice on the HFD diet showed accelerated body weight growth (B) and higher body f

Updated on: July 11,2024 0

Research supports TCM liver-breast cancer theory: Fatty liver linked to deteriorating breast cancer

byThe University of Hong KongA) Trial schematic for establishing an HFD-fed NAFLD-breast cancer mice model. B, C) Mice on the HFD diet showed accelerated body weight growth (B) and higher body f

Updated on:July 11,2024 0

Microproteins exclusively produced in liver tumors could lead to cancer vaccines

by IMIM (Hospital del Mar Medical Research Institute)Credit: Pixabay/CC0 Public DomainA study led by the Hospital del Mar Research Institute, with Cima University of Navarra and Pompeu Fabra Universit

Updated on: July 11,2024 0

Microproteins exclusively produced in liver tumors could lead to cancer vaccines

by IMIM (Hospital del Mar Medical Research Institute)Credit: Pixabay/CC0 Public DomainA study led by the Hospital del Mar Research Institute, with Cima University of Navarra and Pompeu Fabra Universit

Updated on:July 11,2024 0

Proteogenomics analysis of high-grade gliomas offers hints on tumor evolution

byJosep Carreras Leukaemia Research InstituteGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.06.004In August 2023, a team of researchers including Dr. Eduard

Updated on: July 11,2024 0

Proteogenomics analysis of high-grade gliomas offers hints on tumor evolution

byJosep Carreras Leukaemia Research InstituteGraphical abstract. Credit:Cancer Cell(2024). DOI: 10.1016/j.ccell.2024.06.004In August 2023, a team of researchers including Dr. Eduard

Updated on:July 11,2024 0

New Co-STAR T cells show promise for treating cancers in laboratory study

byJohns Hopkins University School of MedicineNew cell type, called Co-STAR, fights cancer cells. Credit: Elizabeth CookUsing genetic engineering techniques, investigators at the Johns Hopkins Ki

Updated on: July 11,2024 0

New Co-STAR T cells show promise for treating cancers in laboratory study

byJohns Hopkins University School of MedicineNew cell type, called Co-STAR, fights cancer cells. Credit: Elizabeth CookUsing genetic engineering techniques, investigators at the Johns Hopkins Ki

Updated on:July 11,2024 0

Targeting ABC transporters in pancreatic ductal carcinoma—past, present, or future?

by Impact Journals LLCRole for ABCB1 in PDAC chemoresistance. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28597A new editorial paper titled "Targeting ABC transporters in PDAC—p

Updated on: July 11,2024 0

Targeting ABC transporters in pancreatic ductal carcinoma—past, present, or future?

by Impact Journals LLCRole for ABCB1 in PDAC chemoresistance. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28597A new editorial paper titled "Targeting ABC transporters in PDAC—p

Updated on:July 11,2024 0

3D genome features point to possible therapeutic target for aggressive and deadly pediatric brain tumors

by Fabienne Landry,McGill University Health CentreCredit:Cell(2024). DOI: 10.1016/j.cell.2024.06.023Posterior fossa group A (PFA) ependymoma are rare, treatment-resistant pediatric t

Updated on: July 11,2024 0

3D genome features point to possible therapeutic target for aggressive and deadly pediatric brain tumors

by Fabienne Landry,McGill University Health CentreCredit:Cell(2024). DOI: 10.1016/j.cell.2024.06.023Posterior fossa group A (PFA) ependymoma are rare, treatment-resistant pediatric t

Updated on:July 11,2024 0

Measuring tumor infiltrating lymphocytes predicts long term outcomes for type of early breast cancer

byQueen Mary, University of LondonBenefit of radiotherapy in preventing IBE by CPath TIL categories. Credit:The Lancet Digital Health(2024). DOI: 10.1016/S2589-7500(24)00116-XResearc

Updated on: July 11,2024 0

Measuring tumor infiltrating lymphocytes predicts long term outcomes for type of early breast cancer

byQueen Mary, University of LondonBenefit of radiotherapy in preventing IBE by CPath TIL categories. Credit:The Lancet Digital Health(2024). DOI: 10.1016/S2589-7500(24)00116-XResearc

Updated on:July 11,2024 0

Advances in Understanding the Role of TREM2+ Macrophages in Breast Cancer Lung Metastasis

Updated on: July 10,2024 0

Advances in Understanding the Role of TREM2+ Macrophages in Breast Cancer Lung Metastasis

Updated on:July 10,2024 0

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on: July 10,2024 0

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on:July 10,2024 0